Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

Aflac Incorporated

COLUMBUS, Ga. , Oct. 2, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025.

Aflac Incorporated to Release Third Quarter Results and CFO Video Update on November 4, 2025 and Host Webcast on November 5, 2025

AFL's sales surge in Japan and the United States, but declining cash flows raise questions over its growth flexibility.

Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma

Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Aflac (AFL) Upgraded to Buy: Here's What You Should Know

Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure

Many investors focus on the dividend yield, but not much on the dividend growth.

3 Dividend Growth Stocks That Can Double Your Income

Coach Saban and Coach Prime reunite with Aflac in annual college football campaign to help fans tackle the chaos of medical bills when health insurance falls short COLUMBUS, Ga. , Aug. 28, 2025 /PRNewswire/ -- Just as the college football landscape feels more unpredictable than ever, so too does the growing challenge of medical debt for Americans.

Amid college football uncertainty, the Aflac Duck takes charge as commissioner

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY in August.

Best Dividend Aristocrats For September 2025

Buy Aflac for its high-interest rate sensitivity, superior financial strength, and best-in-class capital return strategy amid a steepening yield curve. Aflac's dominant Japan exposure, iconic brand, low debt/equity, and consistent dividend growth set it apart from peers like MetLife and Prudential. AFL offers a compelling 2.5x risk/reward to a $120 target (vs. $102 stop), supported by historical outperformance and a temporary slowdown in price momentum.

Aflac: Best-In-Class Life Insurer Poised To Benefit From A Steepening Yield Curve

I am downgrading AFL to a hold due to slowing revenue and earnings growth and a premium valuation versus peers. AFL's Q2 results showed declining revenue and EPS, with investment losses and Japan segment weakness offsetting US segment growth. Despite a strong balance sheet and impressive dividend growth history, current valuation metrics limit near-term upside potential.

Aflac: Q2 Earnings Indicate Slowing Growth (Rating Downgrade)

All You Need to Know About Aflac (AFL) Rating Upgrade to Buy

Nearly 3 in 4 employees experience workplace stress or anxiety while covering for a peer 1 COLUMBUS, Ga. , Aug. 21, 2025 /PRNewswire/ -- Key findings from the second annual Time Away Study 1 released by Aflac, the leading provider of health supplemental insurance in the U.S.,2 reveal the significant physical, mental and professional challenges faced by employees who assume additional work when a co-worker is on leave.

Aflac study reveals the impact of paid leave on employers and employees

On 8/20/25, Loews, AFLAC, and Marketaxess Holdings will all trade ex-dividend for their respective upcoming dividends. Loews will pay its quarterly dividend of $0.0625 on 9/2/25, AFLAC will pay its quarterly dividend of $0.58 on 9/2/25, and Marketaxess Holdings will pay its quarterly dividend of $0.76 on 9/3/25.

Ex-Dividend Reminder: Loews, AFLAC And Marketaxess Holdings

AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.

Aflac Loads the Buyback Cannon as New Sales Signal Strength

COLUMBUS, Ga. , Aug. 12, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has authorized the purchase of up to 100 million shares of its common stock.

Aflac Incorporated Announces Increase in Shares Authorized for Repurchase

AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.

Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales

Aflac Incorporated (NYSE:AFL ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Daniel Paul Amos - Chairman & CEO David Young - Corporate Participant Koichiro Yoshizumi - Senior Managing Exec. Officer and Asst.

Aflac Incorporated (AFL) Q2 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Aflac (AFL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Aflac (AFL) Q2 Earnings

Aflac (AFL) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.83 per share a year ago.

Aflac (AFL) Q2 Earnings and Revenues Top Estimates

Health and life insurer Aflac on Tuesday beat Wall Street estimates for second quarter profit, driven by steady premium gains in the United States offset investment losses.

Insurer Aflac tops quarterly profit estimates on steady US premium gains

COLUMBUS, Ga. , Aug. 5, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its second quarter results.

Aflac Incorporated Announces Second Quarter Results, Reports Second Quarter Net Earnings of $599 Million, Declares Third Quarter Dividend

Real-time stock quote and overview for AFL